This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Diabetic nephropathy (Type I diabetics, secondary prev.)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • hypertension in type I diabetics is often an indication of diabetic nephropathy

  • in type I diabetics blood pressure reduction and ACE inhibitors slow the rate of decline of renal function in overt diabetic nephropathy; also they delay the progression from microalbuminuric phase to overt nephropathy

  • ACE inhibition should be titrated to the maximum dose tolerated and recommended

  • the target blood pressure is described in the menu item

  • combination therapy is invariably required to achieve blood pressure targets

  • even in the presence of a normal blood pressure Type I diabetics with persistent microalbuminuria or proteinuria may also benefit from ACE-inhibition titrated to the recommended maximum dose

  • in the presence of frank proteinuria, in addition to BP control with ACE inhibitors; some suggest protein intake should be reduced to <0.6 g/kg body weight/day

  • measures should also be taken to alter other risk factors such as smoking, obesity and dyslipidaemia

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.